World Whole Genome and Exome Sequencing Market Report 2023-2027: Pathogen Challenges, Diagnostic Factors, Interpreting the Code, Fertility Technology Driving Growth
ResearchAndMarkets.com has released a new report on the Whole Genome and Exome Sequencing market, forecasting growth from 2023 to 2027. The report includes detailed analyses across 14 countries and 5 regions, emphasizing the rapid decrease in sequencing costs and the explosion of market entrants. It addresses major trends like Direct to Consumer Testing, the implications of genomic sequencing for newborns, and the role of innovative technologies. The report outlines both growth drivers, such as advancements in fertility technology and pathogen testing, and challenges including regulatory hurdles in DTC-WGS.
- Increasing demand for Whole Genome Sequencing due to declining costs.
- Growth in Direct to Consumer Testing expected.
- Innovative technologies driving market expansion.
- Increased competition leading to lower pricing.
- Healthcare costs concerns that may restrict growth.
- Regulatory challenges for Direct to Consumer testing.
The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?
The plummeting costs for Whole Genome Sequencing are creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.
Key Topics Covered:
Market Overview
Market Participants Play Different Roles
- Instrument Manufacturer
- Independent lab specialized/esoteric
- Independent lab national/regional
- Independent lab analytical
- Public National/regional lab
- Hospital lab
- Physician lab
DTC Lab Sequencing Labs - Audit body
Whole Genome Sequencing - Markets, Examples and Discussion
- Direct to Consumer - Two Approaches
- The New Age of Medical Information
- Dangers in DTC-WGS - Health Costs and Regulation
- Newborn and Prenatal - A
Brave New World - DTC - How Many Segments?
- Research Markets
- Research Funding and Capital Expense
- WGS Datasets Preferred
- Existing research repurposed
- Organism Wide Market
- Service Suppliers Respond
- Clinical - Understanding Germline and Somatic
- Somatic - Chasing Mutations and Pharmacogenomics
- Pathogen Testing
- The Hepatitis C Story
- Will the Microbiology Department Disappear?
- AgriBio - Big Business
- GMO is Here to Stay
- WGS Benefits and Risks
- The New Agriculture
Industry Structure
- Hospital's Testing Share
- Economies of Scale
- Instrument Manufacturer Role
- Healthcare Industry Impacts - Still Struggling
- Can the Healthcare Industry Adapt?
- Genetic Counselling as an Industry
- WGES Adoption and Cannibalization
- The Meaning of Grail
Market Trends
Factors Driving Growth
- Diagnostic Factors
- Interpreting the Code Otherwise
- Changes in Agriculture
- Fertility Technology Comes of Age
- Pathogen Challenges
Factors Limiting Growth
- Increased Competition Lowers Price
- Lower Costs
- Healthcare Cost Concerns Curtail Growth
- Wellness has a downside
GMO Opposition Movement
Sequencing Instrumentation
- Instrumentation Tenacity
- Declining Cost Changes Industry Structure
- LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS
- llumina
- ION
- Pacific Biosystems
- Roche
- SOLiD
- Oxford Nanopore
- What is Oxford Nanopore Sequencing?
- What can Oxford Nanopore Sequencing be used for?
- Oxford Nanopore Products
- Long Reads - Further Segmentation
- Linked Reads
- Targeted Sequencing Adopts CRISPR
- New Sequencing Technologies
- RNAP sequencing
- In vitro virus high-throughput sequencing
- Tunnelling currents DNA sequencing
- Sequencing by hybridization
- Sequencing with mass spectrometry
- Microfluidic Sanger sequencing
- Microscopy-based techniques
WGES Recent Developments
- Genomics
England , Aims to Sequence 100K Newborns - Juno Diagnostics NIPT With At-Home Sample Collection
- Cardio Diagnostics Launches Genetic Cardio Risk Test
- Universal Genetic Testing in Breast Cancer Further Supported
- Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
MyOme Lands Investment for WGS- GenomSys Gains CE Mark for
New Genomic Analysis Software - WGS Finds Lung Cancers Fall Into Molecular Subtypes
- Testing Distinguishes Benign Tumors From Precancerous Condition
- Plan to Sequence All Newborns in
UK - Clear Labs Raises
$60M - Variantyx Expands Into Prenatal, Cancer Testing
- Whole-Genome Sequencing Aids Diagnosis in
Stockholm - Variantyx Raises
$20M - Nonacus WGS Service for
SARS-CoV-2 Laboratories - Center to Report Risk Scores in Clinical WGS
- Stanford Launches WGS for Cardiovascular Testing
- Illumina and NY Healthcare Partner on Clinical WGS
- Increased Adoption of WGS Needs Acceptance by Payors, Providers
- Veritas Intercontinental Completes
€5M Series B Financing Round - M2GEN and Discovery Life Sciences in Bioinformatics Agreement
- Genomics England Adopts Quantum ActiveScale Object Storage
- GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx
NHS Wales Introduces WGS for Critically Ill Newborns- Illumina Achieves EAU for NGS-Based SARS-CoV-2 Test
- C2i Genomics to Launch Trials for MRD Detection Tech
- Roche Acquires Sequencing Company Stratos Genomics
UK COVID-19 Sequencing Consortium Launches- Invitae Acquires Three Companies: YouScript, Genelex, Diploid
- Experience From
Centralized Genomic Medicine Lab - MGI to Enable
$100 - Nebula Genomics offers
$299 - Team to Study Campylobacter Omics
- Veritas Genetics Restarts US Business
- NEOGEN, Gencove partner to advance animal genomics
UK Whole-Genome Sequencing Project Obtains£200M - WGS may help with disease outbreaks
- Veritas Cuts WGS Price by
40% - Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing
- Machine-learning system used to diagnose genetic diseases
- Whole Genome Sequencing for healthy creates controversy
- Nebula Genomics Offers FREE Whole Genome Sequencing
Profiles of Key Companies
- 10x Genomics, Inc
- Diagnostics
23andME Inc - Abbott Laboratories
AccuraGen Inc - Adaptive Biotechnologies
Admera Health, LLC - Agilent/Dako
Akonni Biosystems - Amoy Diagnostics Co., Ltd
Ancestry.com LLC - Anchor Dx
ARUP Laboratories Baylor Miraca Genetics Laboratories Beckman Coulter Diagnostics Becton , Dickinson and Company- BGI Genomics Co. Ltd
- Bioarray Genetics
- Biocept, Inc.
- Biodesix Inc.
- BioFluidica
BioGenex - Biolidics Ltd
- bioMerieux Diagnostics
- Bioneer Corporation
- Bio-Rad Laboratories, Inc
- Bio-Techne
- C2i Genomics
Caris Molecular Diagnostics - CellMax Life
- Centogene
- Circulogene
Clear Labs - Clinical Genomics
Complete Genomics, Inc. - ABGI Company Dante Labs Datar Cancer Genetics Limited Day Zero Diagnostics .- Diasorin S.p.A
- Epic Sciences
- Epigenomics AG
- Eurofins Scientific
- Excellerate Bioscience
- Fabric Genomics
- Freenome
FUJIFILM Wako Diagnostics Fujirebio - Fulgent Genetics
GE Global Research - Gencove
- Genedrive
GeneFirst Ltd Genetron Holdings Genewiz - Genomics
England Genomics Personalized Health (GPH)- GenomOncology
Genzyme Corporation - Grifols
- Guardant Health
- Guardiome
- HeiScreen
- Helix
Helomics - Hologic
- HTG Molecular Diagnostics
Human Longevity, Inc - iCellate
- Illumina
- Incell Dx
Inivata - Invitae Corporation
- Invivoscribe
- Karius
- Lunglife AI Inc
- Macrogen
MDNA Life SCIENCES, Inc MDx Health - Medgenome
- Meridian Bioscience
- Mesa Biotech (Thermo Fisher)
- Mesa Laboratories, Inc
- miR Scientific
MNG Labs - NantHealth, Inc
- Natera
- Nebula Genomics
- NeoGenomics
New England Biolabs, Inc Novogene Bioinformatics Technology Co., Ltd - Omega Bioservices
- Oncocyte
- OncoDNA
- OpGen
ORIG3N, Inc Origene Technologies - Oxford Nanopore Technologies
- Panagene
- Pathogenomix
- Perkin Elmer
Personal Genome Diagnostics - Personalis
- Precipio
- PrecisionMed
Promega Protagen Diagnostics - Qiagen
QuantuMDx - Regeneron Pharmaceuticals
Roche Molecular Diagnostics - Roswell Biotechnologies
- Seegene
- Sequencing.com
- Siemens Healthineers
- simfo
GmbH Singlera Genomics Inc - SkylineDx
- Standard BioTools
Sure Genomics, Inc - Sysmex
- Sysmex Inostics
Tempus Labs, Inc - Thermo Fisher Scientific Inc
- Variantyx
- Volition
- Vyant Bio
For more information about this report visit https://www.researchandmarkets.com/r/a4pjsi-genome-and?w=5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:SOURCE
FAQ
What does the new report on GTH cover?
What are the key growth factors for the GTH market from 2023 to 2027?
How many countries are analyzed in the GTH market report?
What challenges does the GTH market face?
What is the significance of Direct to Consumer Testing in the GTH report?
